Correlation Between Dynavax Technologies and China Pharma

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Dynavax Technologies and China Pharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Dynavax Technologies and China Pharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Dynavax Technologies and China Pharma Holdings, you can compare the effects of market volatilities on Dynavax Technologies and China Pharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Dynavax Technologies with a short position of China Pharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Dynavax Technologies and China Pharma.

Diversification Opportunities for Dynavax Technologies and China Pharma

-0.75
  Correlation Coefficient

Pay attention - limited upside

The 3 months correlation between Dynavax and China is -0.75. Overlapping area represents the amount of risk that can be diversified away by holding Dynavax Technologies and China Pharma Holdings in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on China Pharma Holdings and Dynavax Technologies is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Dynavax Technologies are associated (or correlated) with China Pharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of China Pharma Holdings has no effect on the direction of Dynavax Technologies i.e., Dynavax Technologies and China Pharma go up and down completely randomly.

Pair Corralation between Dynavax Technologies and China Pharma

Given the investment horizon of 90 days Dynavax Technologies is expected to generate 0.32 times more return on investment than China Pharma. However, Dynavax Technologies is 3.1 times less risky than China Pharma. It trades about 0.02 of its potential returns per unit of risk. China Pharma Holdings is currently generating about -0.05 per unit of risk. If you would invest  1,190  in Dynavax Technologies on October 3, 2024 and sell it today you would earn a total of  93.00  from holding Dynavax Technologies or generate 7.82% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthWeak
Accuracy100.0%
ValuesDaily Returns

Dynavax Technologies  vs.  China Pharma Holdings

 Performance 
       Timeline  
Dynavax Technologies 

Risk-Adjusted Performance

8 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Dynavax Technologies are ranked lower than 8 (%) of all global equities and portfolios over the last 90 days. In spite of fairly weak basic indicators, Dynavax Technologies showed solid returns over the last few months and may actually be approaching a breakup point.
China Pharma Holdings 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days China Pharma Holdings has generated negative risk-adjusted returns adding no value to investors with long positions. Despite fairly strong technical indicators, China Pharma is not utilizing all of its potentials. The latest stock price confusion, may contribute to short-horizon losses for the traders.

Dynavax Technologies and China Pharma Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Dynavax Technologies and China Pharma

The main advantage of trading using opposite Dynavax Technologies and China Pharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Dynavax Technologies position performs unexpectedly, China Pharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in China Pharma will offset losses from the drop in China Pharma's long position.
The idea behind Dynavax Technologies and China Pharma Holdings pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Cryptocurrency Center module to build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency.

Other Complementary Tools

Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
USA ETFs
Find actively traded Exchange Traded Funds (ETF) in USA